Prilenia
prilenia.comLocations
North Holland, Netherlands · Herzliya, Israel · Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · Biotechnology Research · Health Care · Life Science · Pharmaceutical
Size
51 - 200 employees
Stage
Series B
founded in
2018
Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, an oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. The company was founded in 2018 and is based in Israel, the Netherlands, and Boston.
Something looks off?Open jobs at Prilenia
On-site & Remote
Seniority
Salary